Stay updated on PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.

Latest updates to the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check18 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check61 days agoChange DetectedThe web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here's how you know' has been modified, suggesting a change in the way information is presented.SummaryDifference1.0%
- Check68 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check111 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.